Act Capital Management, LLC 13F 持仓 · 2026年Q2
Act Capital Management 在 2026年Q2（报告期截至 2026-06-30）的 SEC 13F 申报中报告了 62 只证券，申报市值合计 1.53 亿美元。前几大持仓：KRYS（10.93%）、TGTX（9.01%）、ABVX（8.44%）。本季前 25 大持仓中：新建仓 8 只、增持 8 只、减持 6 只。
| 排名 | 代码 | 公司 | 市值 | 占组合 | 股数 | 变动 |
|---|---|---|---|---|---|---|
| 1 | KRYS | KRYSTAL BIOTECH INC | $16.7M | 10.93% | 45,000 | 减持 |
| 2 | TGTX | TG THERAPEUTICS INC | $13.8M | 9.01% | 251,025 | 增持 |
| 3 | ABVX | ABIVAX SA | $12.9M | 8.44% | 97,000 | 增持 |
| 4 | CVX | CHEVRON CORP | $12.4M | 8.12% | 75,000 | 持平 |
| 5 | XOM | EXXON MOBIL CORP | $10.7M | 7.01% | 78,500 | 增持 |
| 6 | ARWR | ARROWHEAD PHARMACEUTICALS INC | $9.0M | 5.86% | 110,100 | 增持 |
| 7 | VKTX | VIKING THERAPEUTICS INC | $8.2M | 5.33% | 209,300 | 持平 |
| 8 | CELC | CELCUITY INC | $6.5M | 4.25% | 62,150 | 减持 |
| 9 | NKTR | NEKTAR THERAPEUTICS | $6.2M | 4.07% | 89,300 | 增持 |
| 10 | TSLA | TESLA INC | $4.5M | 2.97% | 10,800 | 新建仓 |
| 11 | CYTK | CYTOKINETICS INC | $4.0M | 2.64% | 47,500 | 减持 |
| 12 | ASTS | AST SPACEMOBILE INC | $3.9M | 2.53% | 43,500 | 新建仓 |
| 13 | PVLA | PALVELLA THERAPEUTICS INC | $3.4M | 2.25% | 22,500 | 新建仓 |
| 14 | AMZN | AMAZON.COM INC | $3.1M | 2.01% | 12,900 | 减持 |
| 15 | NUVB | NUVATION BIO INC | $3.0M | 1.93% | 520,000 | 增持 |
| 16 | XENE | XENON PHARMACEUTICALS INC | $2.9M | 1.89% | 48,000 | 增持 |
| 17 | ET | ENERGY TRANSFER L P | $2.5M | 1.66% | 133,100 | 持平 |
| 18 | BE | BLOOM ENERGY CORP | $2.3M | 1.48% | 7,500 | 增持 |
| 19 | FCX | FREEPORT-MCMORAN INC | $2.0M | 1.34% | 32,500 | 减持 |
| 20 | NBIS | NEBIUS GROUP NV | $1.9M | 1.23% | 6,800 | 新建仓 |
| 21 | ALMS | ALUMIS INC | $1.5M | 0.95% | 51,600 | 减持 |
| 22 | AMBA | AMBARELLA INC | $1.4M | 0.90% | 16,000 | 新建仓 |
| 23 | CBRS | CEREBRAS SYSTEMS INC | $1.2M | 0.81% | 5,600 | 新建仓 |
| 24 | DFTX | DEFINIUM THERAPEUTICS INC | $1.2M | 0.77% | 25,000 | 新建仓 |
| 25 | NOK | NOKIA CORP | $1.1M | 0.71% | 82,000 | 新建仓 |
来源：SEC 13F 申报文件 · 截至 2026-06-30
本期 13F-HR 中的全部持仓，以及相对上季度的变化。
13F 持仓，最新季度
来源SEC EDGAR13F-HR